EN
HI
Aspira Pathlab & Diagnostics Chart
Aspira Pathlab & Diagnostics Share Key Metrics
Volume
841.00
Market Cap
123.21 CR
LTQ@LTP
587@122.00
ATP
120.97
Var Margin
100 %
Circuit Range
117.35-122.05
Delivery %
100 %
Value
1.02 L
ASM/GSM
No
Market Lot
1
Summary
Aspira Pathlab & Diagnostics share price is ₹122 as of 18 Jun, 2026. The stock Aspira Pathlab & Diagnostics intraday movement has stayed between ₹118.00 and ₹122.00, while on a 52-week basis,Aspira Pathlab & Diagnostics price 52 week high is ₹135.88 & its 52 week low is ₹49.00.
In terms of trading activity, Aspira Pathlab & Diagnostics has recorded a volume of 841 shares, The Aspira Pathlab & Diagnostics has a market cap of ₹10293000 CR. The stock’s Average Traded Price (ATP) stands at ₹120.97, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 587 @ ₹122.00.
Aspira Pathlab & Diagnostics operates within a circuit range of ₹117.35 – ₹122.05, with a Value of ₹1.02 L. The Delivery Percentage for the day is 100%. Additionally, Aspira Pathlab & Diagnostics currently falls under the No framework, and trades with a market lot size of 1.
Aspira Pathlab & Diagnostics Fundamentals
P/E Ratio
51.36
P/B Ratio
9.75
Div. Yield
0
Sector P/E
55.87
Sector P/B
-15.45
Sec. Div. Yield
0.18
Aspira Pathlab & Diagnostics Resistance and Support
Pivot 118.8
Resistance
First Resistance
120.6
Second Resistance
121.5
Third Resistance
123.3
Support
First Support
117.9
Second Support
116.1
Third Support
115.2
Aspira Pathlab & Diagnostics Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-23 | Audited Results |
| 2026-02-10 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-16 | Audited Results |
| 2025-02-07 | Quarterly Results |
Aspira Pathlab & Diagnostics News
Aspira Pathlab & Diagnostics Ltd - 540788 - Disclosure Under Regulation 30(LODR) For Classification Of Mr. Nikunj Mange And Mr. Jay Arvind Bhanushali As Promoters Of The Company
Aspira Pathlab announced a change in its Promoter category after completing an Open Offer. Mr. Nikunj Mange and Mr. Jay Arvind Bhanushali, previously directors, are now classified as Promoters, formalizing their roles.
Jun 11 2026 16:18:11
Aspira Pathlab & Diagnostics Ltd - 540788 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Aspira Pathlab's promoter group, led by Shraddha Jagdish Bhanushali, acquired 22.18% of the company's equity shares through an open offer. This increased their total shareholding to 46.00%, signaling enhanced promoter confidence and control.
Jun 11 2026 10:23:08
Read More
Aspira Pathlab & Diagnostics Management
| Name | Position |
|---|---|
| Haseeb A Drabu | Chairman |
| Pankaj Shah | Managing Director & Chief Executive Officer |
Aspira Pathlab & Diagnostics Similar Stocks
Source Natural Foods and Herbal Supplements Ltd.
108.00
0.10 (0.09%)
Bal Pharma Ltd.
88.86
1.25 (1.43%)
Lasa Supergenerics Ltd.
7.80
0.33 (4.42%)
Raaj Medisafe India Ltd.
75.01
1.02 (1.38%)
Mercury Laboratories Ltd.
758.80
8.25 (1.10%)
Bharat Immunologicals & Biologicals Corporation Ltd.
17.10
0.05 (0.29%)
Concord Drugs Ltd.
76.62
-1.31 (1.68%)
Pharmaids Pharmaceuticals Ltd.
33.00
0.72 (2.23%)
Fortis Malar Hospitals Ltd.
52.26
-0.83 (1.56%)
Aspira Pathlab & Diagnostics FAQs
The Buying Price of Aspira Pathlab & Diagnostics share is 122 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Aspira Pathlab & Diagnostics stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aspira Pathlab & Diagnostics, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Aspira Pathlab & Diagnostics shares is 51.36. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Aspira Pathlab & Diagnostics shares is 9.75. Useful to assess the stock's value relative to its book value.
To assess Aspira Pathlab & Diagnostics’s valuation compare Sector P/E, P/B which are 55.87 & -15.45 with sector averages, along with growth rates and financial metrics.
The Market Cap of Aspira Pathlab & Diagnostics is 123.21 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Aspira Pathlab & Diagnostics share price is 135.88 & 49.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Aspira Pathlab & Diagnostics belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
